These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2106528

  • 1. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H, Komaki G, Matsubayashi S, Kobayashi N, Mori K, Nakagawa T, Truong MP, Walter RM, Kumagai LF.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
    [Abstract] [Full Text] [Related]

  • 2. Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa.
    Rolla M, Andreoni A, Belliti D, Ferdeghini M, Cristofani R, Müller EE.
    Endocrinol Exp; 1990 Mar; 24(1-2):195-204. PubMed ID: 2113857
    [Abstract] [Full Text] [Related]

  • 3. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.
    Rolla M, Andreoni A, Belliti D, Cristofani R, Ferdeghini M, Müller EE.
    Biol Psychiatry; 1991 Jun 01; 29(11):1079-91. PubMed ID: 1908328
    [Abstract] [Full Text] [Related]

  • 4. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L, Arvat E, Valetto MR, Ramunni J, Di Vito L, Maccagno B, Camanni F, Ghigo E.
    Biol Psychiatry; 1998 Feb 01; 43(3):181-7. PubMed ID: 9494699
    [Abstract] [Full Text] [Related]

  • 5. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug 01; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 6. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1997 May 01; 46(5):539-43. PubMed ID: 9231048
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
    Müller EE, Rolla M.
    Psychiatry Res; 1996 Apr 16; 62(1):51-63. PubMed ID: 8739115
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
    Murialdo G, Zerbi F, Filippi U, Tosca P, Fonzi S, Di Paolo E, Costelli P, Porro S, Polleri A, Savoldi F.
    Neuropsychobiology; 1996 Apr 16; 24(3):129-34. PubMed ID: 1983729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.
    De Marinis L, Folli G, D'Amico C, Mancini A, Sambo P, Tofani A, Oradei A, Barbarino A.
    J Clin Endocrinol Metab; 1988 Mar 16; 66(3):598-604. PubMed ID: 3127419
    [Abstract] [Full Text] [Related]

  • 16. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level.
    Casanueva FF, Villanueva L, Dieguez C, Cabranes JA, Diaz Y, Szoke B, Scanlon MF, Schally AV, Fernandez-Cruz A.
    J Clin Endocrinol Metab; 1986 Jan 16; 62(1):186-91. PubMed ID: 3079600
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
    Gianotti L, Fassino S, Daga GA, Lanfranco F, De Bacco C, Ramunni J, Arvat E, MacCario M, Ghigo E.
    Clin Endocrinol (Oxf); 2000 Jun 16; 52(6):713-20. PubMed ID: 10848875
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
    Lomeo A, Mazzocchi G, Sessarego P, Torre R, Delmonte P, Giusti M.
    Recenti Prog Med; 1989 Nov 16; 80(11):569-73. PubMed ID: 2516349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.